AZN
AstrazenecaยทNYSE
--
--(--)
--
--(--)
Is AZN fundamentally strong?
- AZN scores 0.00/10 on fundamentals and holds a Fair valuation at present. Backed by its 18.19% ROE, 16.18% net margin, 30.41 P/E ratio, 6.22 P/B ratio, and 44.87% earnings growth, these metrics solidify its Neutral investment rating.
